{'fraction_non_alphanumeric': 0.02178217821782178, 'fraction_numerical': 0.0, 'mean_word_length': 5.571428571428571, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Drugs for Children

The “Therapeutic Orphan” status of children is gradually improving, but our efforts to eliminate off‐label/off‐evidence use must be sustained for safer and more effective pediatric drug therapy. This is even more important in resource‐scarce settings, because of the increasing child population in those regions. The juncture of pediatric pharmacology and global child health represents an emerging field of clinical pharmacology illuminating a crucial societal need on a global scale.